Condition
Thermogenesis
Total Trials
6
Recruiting
1
Active
1
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
Early P 1 (1)
P 1 (2)
Trial Status
Completed5
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05990387Phase 1Completed
MIrabegron and Physiological Function in Cold Environments
NCT06803069Recruiting
Investigation of the Mechanisms of the Tendency to Hypothermia in Newborns and Premature Neonates
NCT04766021Phase 1Completed
Mirabegron and Physiological Function in Cold Environments
NCT06121817Not ApplicableCompleted
Thermogenic Effect and Metabolic Responses of Durian
NCT05294965Early Phase 1CompletedPrimary
Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue
NCT01898949Not ApplicableCompletedPrimary
Stimulation of Diet-Induced Thermogenesis by Cold-Exposure
Showing all 6 trials